ArticleDiscover oncology2025
Knowledge mapping of ultrasound technology and triple-negative breast cancer: a visual and bibliometric analysis.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ultrasound medicine in the era of precision theranostics: Mechanisms, molecular strategies, and clinical translation.Iranian journal of basic medical sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveThis study aims to explore the application of ultrasound technology in triple-negative breast cancer (TNBC) using bibliometric methods. It presents a visual knowledge map to exhibit global research dynamics and elucidates the research directions, hotspots, trends, and frontiers in this field.
methodsThe Web of Science Core Collection database was used, and CiteSpace and VOSviewer software were employed to visualize the annual publication volume, collaborative networks (including countries, institutions, and authors), citation characteristics (such as references, co-citations, and publications), as well as keywords (including emergence and clustering) related to ultrasound applications in TNBC over the past 15 years.
resultsA total of 310 papers were included. The first paper was published in 2010, and after that, publications in this field really took off, especially after 2020. China emerged as the leading country in terms of publication volume, while Shanghai Jiao Tong University had the highest output among institutions. Memorial Sloan Kettering Cancer Center was recognized as a key research institution within this domain. Adrada BE was the most prolific author in terms of publication count. Ko Es held the highest citation frequency among authors. Co-occurrence analysis of keywords revealed that the top three keywords by frequency were "triple-negative breast cancer," "breast cancer," and "sonography." The timeline visualization indicated a strong temporal continuity in the clusters of "breast cancer," "recommendations," "biopsy," "estrogen receptor," and "radiomics." The keyword with the highest emergence value was "neoplasms" (6.80). Trend analysis of emerging terms indicated a growing focus on "machine learning approaches," "prognosis," and "molecular subtypes," with "machine learning approach" emerging as a significant keyword currently.
conclusionThis study provided a systematic analysis of the current state of ultrasound technology applications in TNBC. It highlighted that "machine learning methods" have emerged as a central focus and frontier in this research area, both presently and for the foreseeable future. The findings offer valuable theoretical insights for the application of ultrasound technology in TNBC diagnosis and treatment and establish a solid foundation for further advancements in medical imaging research related to TNBC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.